Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 4, 2010, Pages 903-906

  Stanczyk, Frank Z ^a   Jurow, Jordan ^a   Hsing, Ann W ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL ANTIBODY; ESTRONE SULFATE;

COST BENEFIT ANALYSIS; CROSS REACTION; DIAGNOSTIC TEST; GAS CHROMATOGRAPHY; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MENOPAUSAL SYNDROME; NOTE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EPIDEMIOLOGIC STUDIES; ESTRADIOL; FEMALE; HUMANS; MALE; POSTMENOPAUSE; RADIOIMMUNOASSAY; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 77950845962     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0081     Document Type: Note

References (14)

1. Nisbet JA, Jomain PA. Discrepancies in plasma estradiol values obtained with commercial kits. Clin Chem 1987; 33: 1672.
2. Thomas CMG, van den Berg RJ, Segers MFG. Measurement of serum estradiol: comparison of three "direct" radioimmunoassays and effects of organic solvent extraction. Clin Chem 1987; 33: 1946-1947.
3. Schiøler V, Thode J. Six direct radioimmunoassays of estradiol evaluated. Clin Chem 1988; 34: 949-952
4. Lee CS, Smith NM, Kahn SN. Analytic variability and clinical significance of different assays for serum estradiol. J Reprod Med 1991; 36: 156-160
5. Diver MJ. Monitoring of hormone replacement therapy. Lancet 1992; 340: 1471.
6. Thomas CMG, van den Berg RJ, Segers MFG, Bartelink M-L, Thien T. Inaccurate measurement of 17β-estradiol in serum of female volunteers after oral administration of milligram amounts of micronized 17β-estradiol. Clin Chem 1993; 39: 2341-2342
7. Cook NJ, Read GF. Oestradiol measurement in women on oral hormone replacement therapy: the validity of commercial test kits. Br J Biomed Sci 1995; 52: 97-101.
8. Stanczyk FZ, Cho MM, Endres DB, Morrison JL, Patel S, Paulson RJ. Limitations of direct estradiol and testosterone immunoassay kits. Steroids 2003; 68: 1173-1178
9. 9. Stanczyk FZ. Measurement of serum estradiol levels in postmenopausal women [letter]. JAMA 2002; 288: 450-451 (Pubitemid 34787474)
10. Lee JS, Ettinger B, Stanczyk FZ, et al. Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 2006; 91: 3791-3797
11. Stanczyk FZ, Lee J, Santen R. Standardization of steroid hormone assays: why, how, and when? [commentary]. Cancer Epidemiol Biomarkers Prev 2007; 16: 1713-1719
12. Abraham GE. Solid-phase radioimmunoassay of estradiol-17β. J Clin Endocrinol Metab 1969; 29: 866-870
13. Abraham GE, Odell WD. Solid-phase radioimmunoassay of serum estradiol-17β: a semi-automated approach. In: Peron FG, Caldwell BV, editors. Immunologic methods in steroid determination. New York (NY): Appleton-Century-Crofts; 1970, p. 87-112.
14. Dowsett M, Folkerd E. Deficits in plasma estradiol measurements in studies and management of breast cancer [commentary]. Breast Cancer Res 2005; 7: 1-4.